In this regard, we aimed to investigate the correlation of A2AR with PD-1 and CTLA-4 regulatory proteins to identify the potential interplay between these immunological pathways and consequently emphasize the relevance of combined therapy in human breast cancer. This evidence concerns the gene ADORA2A and breast carcinoma.